• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Bicyclic monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Bicyclic monoterpenoids

Research Briefing on 2-{bicyclo[2.2.1]heptan-2-yl}acetyl chloride (CAS: 54057-58-8) in Chemical Biology and Pharmaceutical Applications

The compound 2-{bicyclo[2.2.1]heptan-2-yl}acetyl chloride (CAS: 54057-58-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and versatile reactivity. This bicyclic derivative, characterized by its norbornane scaffold, serves as a valuable intermediate in the synthesis of complex molecules with potential therapeutic applications. Recent studies have explored its utility in drug discovery, material science, and biocatalysis, highlighting its role in advancing innovative solutions for challenging chemical transformations.

One of the most notable advancements involves the application of 2-{bicyclo[2.2.1]heptan-2-yl}acetyl chloride in the development of novel prodrugs and targeted delivery systems. Researchers have leveraged its reactive acyl chloride moiety to conjugate with bioactive molecules, enhancing their pharmacokinetic properties. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its use in synthesizing ester prodrugs of antiviral agents, significantly improving their bioavailability and tissue penetration. The rigid norbornane framework also contributes to increased metabolic stability, a critical factor in drug design.

In addition to pharmaceutical applications, this compound has shown promise in polymer chemistry. Its ability to act as a cross-linking agent has been exploited in the creation of high-performance biomaterials. A recent ACS Biomaterials Science & Engineering publication reported its incorporation into hydrogels for controlled drug release, where the bicyclic structure imparted mechanical robustness while maintaining biocompatibility. These findings underscore its dual utility in both therapeutic and material science domains.

Mechanistic studies have further elucidated the compound's reactivity patterns. Quantum chemical calculations and kinetic analyses, as detailed in a 2024 Chemical Communications paper, revealed that the steric constraints of the norbornane ring system influence its acylation kinetics, enabling selective reactions under mild conditions. This insight has paved the way for its use in green chemistry initiatives, minimizing the need for harsh reagents or high-energy processes.

Ongoing research is now investigating its potential in biocatalysis. Preliminary data from a multinational collaboration (unpublished, 2024) suggest that enzyme-mediated transformations of 2-{bicyclo[2.2.1]heptan-2-yl}acetyl chloride can yield chiral building blocks for asymmetric synthesis, addressing a longstanding challenge in preparing optically active pharmaceuticals. Such developments align with the industry's shift toward sustainable and stereoselective methodologies.

In conclusion, 2-{bicyclo[2.2.1]heptan-2-yl}acetyl chloride (CAS: 54057-58-8) exemplifies the convergence of structural ingenuity and functional versatility. Its applications span from drug design to advanced materials, supported by rigorous mechanistic understanding. Future directions may explore its role in covalent inhibitor design or as a template for bioactive compound libraries, reinforcing its status as a cornerstone in modern chemical biology research.

• 104-97-2(3-cyclopentylpropanoyl chloride)
• 39098-75-4(3-cyclohexylpropanoyl chloride)
• 19835-38-2(1-Adamantaneacetyl chloride)
• 94487-60-2(4,7-Methano-1H-indene-1-carbonylchloride, octahydro-)
• 101055-79-2(1,4-Methanopentalene-2-carbonyl chloride, octahydro- (9CI))
• 61757-70-8(Bicyclo[2.2.1]heptane-2-acetyl chloride, (1R,2S,4S)-rel-)
• 35202-90-5(bicyclo[2.2.1]heptane-2-carbonyl chloride)
• 23860-35-7(2-cyclohexylacetyl chloride)
• 1122-99-2(Cyclopentylacetyl chloride)
• 101055-82-7(1,4-Methanopentalene-3-carbonyl chloride, octahydro- (9CI))